Dreamfold
Dreamfold builds generative algorithms that design precision medicines to tackle cancers, immune disorders, infectious diseases and other complex conditions. It combines machine learning, generative models and 3D structural protein modeling with synthetic biology to create programmable protein therapeutics and other smart drug candidates. The company operates as a biotechnology-focused SaaS platform and integrates with large-scale compute and engineering stacks including Ray, AWS, Google Cloud Platform and Nvidia hardware. Typical customers are biotechnology and pharmaceutical companies seeking computationally driven drug design workflows. Dreamfold emphasizes patient-centric generative design to reduce the time, cost, and risk of early-stage drug discovery.
Dreamfold
Dreamfold builds generative algorithms that design precision medicines to tackle cancers, immune disorders, infectious diseases and other complex conditions. It combines machine learning, generative models and 3D structural protein modeling with synthetic biology to create programmable protein therapeutics and other smart drug candidates. The company operates as a biotechnology-focused SaaS platform and integrates with large-scale compute and engineering stacks including Ray, AWS, Google Cloud Platform and Nvidia hardware. Typical customers are biotechnology and pharmaceutical companies seeking computationally driven drug design workflows. Dreamfold emphasizes patient-centric generative design to reduce the time, cost, and risk of early-stage drug discovery.